Documentation of patient withdrawals, retention strategies, and postwithdrawal data practices in cancer clinical trials
A substantial proportion of patients in phase 3 cancer trials withdraw without a specified rationale. Inconsistent withdrawal documentation practices, limited use of a retention strategy, and unclear postwithdrawal data policies highlight the need for standardized approaches to improve trial quality.
Authors
- Kasopefoluwa Y. Oguntuyo (ORCID: https://orcid.org/0000-0001-7824-2892)
- Deborah B. Doroshow (ORCID: https://orcid.org/0000-0002-2221-9818)
- Rodrigo Paredes (ORCID: https://orcid.org/0000-0003-2886-9763)
- Matthew D. Galsky (ORCID: https://orcid.org/0000-0001-7655-9378)
- Alexander B. Karol (ORCID: https://orcid.org/0000-0001-8277-9932)
- Lauren Weintraub (ORCID: https://orcid.org/0009-0009-4406-1255)
- Himanshu Joshi (ORCID: https://orcid.org/0000-0003-0272-0733)
- Anna Argulian
- Yu Fujiwara (ORCID: https://orcid.org/0000-0003-1406-2352)
- Justin Miller (ORCID: https://orcid.org/0000-0002-5309-1570)
Institutions
- Roswell Park Comprehensive Cancer Center (US)
- University of South Florida (US)
- Mount Sinai Hospital (US)
- Tisch Hospital (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Cancer
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1002/cncr.70106
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00